Agilent Adds WTCCC-Designed CNV Chip to Menu to Target Association Studies
April 07, 2009
Agilent Adds WTCCC-Designed CNV Chip to Menu to Target Association Studies
Agilent's Human CNV Association 2x105K microarray, based on a design by the Wellcome Trust Case Control Consortium, is the company's second catalog CNV chip and was designed for studying associations between genomic CNVs and disease.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Aussie Cytogeneticists Say Diagnostics 'Improved' After Switching to Array-Based Testing
February 24, 2009 / BioArray News - Completing Platform Upgrade, Agilent Launches High-Density CGH and CNV Chips and Promises More
March 3, 2009 / BioArray News - Illumina Warns of 'Temporary' Slowdown in GWAS Growth Rate, Posts 36 Percent Rise in Q1 Sales
April 28, 2009 / BioArray News - Genotyping Tech Guide
February 3, 2009 / Genome Technology - Moving Target: CNVs in Disease
April 29, 2009 / Genome Technology